Division of Cardiology, Cardiovascular Performance Program, Massachusetts General Hospital, Boston, MA.
Departments of Orthopedics and Family & Community Medicine, University of California, San Francisco, CA.
Curr Sports Med Rep. 2022 May 1;21(5):159-162. doi: 10.1249/JSR.0000000000000956.
Preparticipation cardiovascular screening, designed to identify cardiovascular pathology responsible for sudden unexpected death, is recommended by all major professional medical organizations overseeing the clinical care of competitive athletes. Data from several large, prospective, cohort studies indicate that cardiac imaging findings consistent with inflammatory heart disease following COVID-19 infection are more common than most forms of heart disease associated with sudden death during exercise. This call-to-action document is intended to provide recommendations about how routine preparticipation cardiovascular screening for young competitive athletes - which has the capacity to detect both COVID-19 cardiovascular complications and pathology unrelated to infection - should be altered to account for recent scientific advances.
参加前心血管筛查旨在识别导致突发性意外死亡的心血管病理,这是所有监督竞技运动员临床护理的主要专业医疗组织都建议进行的。几项大型前瞻性队列研究的数据表明,COVID-19 感染后与炎症性心脏病一致的心脏成像发现比与运动时猝死相关的大多数形式的心脏病更为常见。本行动呼吁文件旨在提供有关如何改变年轻竞技运动员常规参加前心血管筛查的建议,这种筛查有能力检测 COVID-19 心血管并发症和与感染无关的病理,以适应最近的科学进展。